Clinical Trials on Open-angle Glaucoma (OAG)

Total 942 results

University of the Incarnate Word
Guardion Health Sciences, Inc.

Withdrawn

Augmented Macular Pigment-containing Nutraceutical and Central Visual Function

Glaucoma | Glaucoma, Open-Angle | Glaucoma Eye

United States
Glaukos Corporation

Completed

Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One iStent and One iStent Supra

Glaucoma, Open-Angle

Armenia
Ameera Gamal Abdelhameed
Dar Alshifa hospital Kuwait

Completed

Phaco-UCP Versus Phaco Alone for OAG and Cataract

Glaucoma, Open-Angle | Cataract

Egypt
Robert Ritch, MD, LLC.

Completed

A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma (ROCK)

Ocular Hypertension | Open Angle Glaucoma | Exfoliation Syndrome

United States
Ohio State University

Completed

The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study (FLIPR)

Glaucoma, Open-Angle | Eye Diseases

United States
Ain Shams University

Completed

The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases

Glaucoma, Open-Angle | Glaucoma, Neovascular | Glaucoma Secondary
Vold Vision P.L.L.C
Alcon Research

Recruiting

Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery

Glaucoma, Open-Angle | Cataract

United States
Royal Victoria Eye and Ear Hospital
Glaukos Corporation; Centre for Eye Research Australia

Completed

A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent

Glaucoma, Open-Angle

Australia
Columbia University

Completed

Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin)

Glaucoma, Open-Angle | Visual Field Defect, Peripheral

United States
Ridge Eye Care
Alcon Research

Recruiting

Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent

Glaucoma, Open-Angle

United States
Vance Thompson Vision

Withdrawn

Effect of Negative Pressure on Pattern Electroretinography Readings

Ocular Hypertension | Glaucoma | Glaucoma Suspect | Open Angle, Low Risk

United States
National University Hospital, Singapore

Completed

Treatment Outcomes of a Novel Glaucoma Tube Shunt Implant for Intraocular Pressure Control in Eyes With Refractory Glaucoma

Glaucoma | Glaucoma, Open-Angle | Surgery | Intraocular Pressure

Singapore
Allergan

Completed

Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy

Glaucoma, Open-Angle

Israel, United States
Sensimed AG

Completed

IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure

Sleep Apnea, Obstructive | Primary Open-angle Glaucoma

United States
Vold Vision P.L.L.C
Alcon Research

Completed

Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma

Glaucoma, Open-Angle | Cataract | IOL

United States
Allergan

Completed

A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

Glaucoma, Open-Angle

Spain
University of Parma

Completed

Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression

Glaucoma, Open-Angle

Italy
Padagis LLC

Completed

To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

Ocular Hypertension | Glaucoma, Open-Angle

United States
Allergan

Completed

Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States, Singapore, Italy, United Kingdom, Egypt, Korea, Republic of, Argentina, Canada, Colombia, Czechia, Germany, Malaysia, New Zealand, South Africa, Turkey
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

Ocular Hypertension | Glaucoma, Open-Angle

France
Allergan

Completed

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Brazil
Allergan

Completed

Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma, Open-Angle

United States
Allergan

Completed

A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

Ocular Hypertension | Glaucoma, Open-Angle

Korea, Republic of
Allergan

Completed

Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States
Alcon Research

Completed

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

United States
Henner Hanssen
Universitaire Ziekenhuizen KU Leuven; University Hospital, Basel, Switzerland

Recruiting

Exercise Training in Patients With Glaucoma (HIT GLAUCOMA)

Glaucoma, Open-Angle | Exercise Training | Microvascular Health

Switzerland
Papworth Hospital NHS Foundation Trust
Hinchingbrooke Healthcare NHS Trust

Completed

PAIR Study-PAP And IOP Relationship: Study 2 (PAIR2)

Primary Open-angle Glaucoma | Obstructive Sleep Apnoea

United Kingdom
University of Washington

Recruiting

Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States
Laboratorios Sophia S.A de C.V.

Terminated

Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. (PRO-122)

Ocular Hypertension | Glaucoma, Open-Angle

Mexico
Allergan

Completed

An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments

Ocular Hypertension | Glaucoma, Open-Angle

Turkey
Allergan

Completed

Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

China
Allergan

Completed

A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

Austria
Allergan

Completed

Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

United States
Allergan

Completed

Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Canada, United States
Allergan

Completed

GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy

Ocular Hypertension | Glaucoma, Open-Angle

Austria
Allergan

Completed

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

Netherlands
Allergan

Completed

A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

Germany
Allergan

Completed

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Ocular Hypertension | Glaucoma, Open-Angle

Spain
Pfizer

Completed

A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

France, Greece, Ireland, Spain, Sweden, United Kingdom, Belgium, Italy, Netherlands, Germany, Australia, Denmark
Allergan

Completed

Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)

Glaucoma, Open-Angle | Normal Tension Glaucoma

Korea, Republic of
Technische Universität Dresden
Fraunhofer Institute for Ceramic Technologies and Systems IKTS

Completed

Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics (EyeTwin)

Glaucoma | Corneal Astigmatism | Keratoconus | Open Angle Glaucoma | Corneal Ectasia | Corneal Disease | Normal Tension Glaucoma

Germany
Fondazione G.B. Bietti, IRCCS

Recruiting

24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. (HERO)

Ocular Hypertension | Glaucoma, Open-Angle

Italy
AbbVie

Completed

Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States, Australia, Canada, Denmark, France, Germany, Israel, New Zealand, Philippines, Poland, Russian Federation, United Kingdom
BelkinVision

Withdrawn

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population The Zhuiguang Trial

Ocular Hypertension | Glaucoma, Open-Angle
Padagis LLC

Completed

To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

Ocular Hypertension | Glaucoma, Open-Angle

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

Ocular Hypertension | Glaucoma, Open-Angle

Canada, United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada

Ocular Hypertension | Glaucoma, Open-Angle

Canada
Pfizer's Upjohn has merged with Mylan to form Viatris...

Withdrawn

Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device

Ocular Hypertension | Glaucoma, Open-Angle
Aerie Pharmaceuticals

Completed

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

Ocular Hypertension | Glaucoma, Open-Angle

United States
Allergan

Completed

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

United States, Hong Kong, Taiwan, Spain, Israel, Australia, Austria, Belgium, Brazil, Denmark, Hungary, Peru, Philippines, Poland

3

Subscribe